ANDREW JOHN LEPINSKI

Allopathic & Osteopathic Physicians|Urology LINCOLN, NE NPI 1902829989

General Payments — all program years on this page

$4,097.83

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 245
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $393.02 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $393.0221

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $755.6651
2019 $827.8959
2020 $301.3116
2021 $523.8635
2022 $849.2546
2023 $446.8417
2024 $393.0221

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078337534 Janssen Biotech, Inc. $18.68 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078337617 Janssen Biotech, Inc. $13.92 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078337700 Janssen Biotech, Inc. $14.61 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086115002 Bayer Healthcare Pharmaceuticals Inc. $17.27 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086266309 Bayer Healthcare Pharmaceuticals Inc. $14.44 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087139232 Novartis Pharmaceuticals Corporation $21.02 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087139240 Novartis Pharmaceuticals Corporation $14.49 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104163066 ABBVIE INC. $15.69 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104163068 ABBVIE INC. $19.47 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104163070 ABBVIE INC. $16.78 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104163072 ABBVIE INC. $17.57 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117441316 COLOPLAST CORP $16.18 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125509824 IMMUNITYBIO, INC. $16.38 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138583725 Endo USA, Inc. $13.35 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138718472 Tolmar, Inc. $14.36 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139326928 Astellas Pharma US Inc $31.60 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148880848 Sumitomo Pharma America, Inc. $13.71 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148880850 Sumitomo Pharma America, Inc. $16.50 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154948424 Edap Technomed Inc $29.00 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154975515 Edap Technomed Inc $29.00 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154984368 Edap Technomed Inc $29.00 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.